Company Overview
Snapshot
Founded in November 2022 by Lior Erez and Matan Shabat, Intimo Medical operates with 1–10 employees. The company has secured $3.15 million in total capital across 3 funding rounds from 3 investors. In May 2025, Intimo Medical received a grant from the Israel Innovation Authority.
Business overview
Intimo Medical is a Health Tech & Life Sciences company focused on developing advanced gynecology innovations. The company's core product is a versatile Intrauterine 3-Dimensional Device (IU3D) designed to provide hormone-free contraception. This IU3D self-expands to adapt to the uterine cavity, aiming to reduce the risk of uterine injury and enhance user safety and comfort. Intimo Medical operates within the medical devices sector, targeting women's health and healthcare providers with its medical treatment and therapeutics solutions.
Strategic signal
In December 2024, Intimo Medical was one of five startups selected for the Open Accelerator program, promoted by Zcube – Zambon Research Venture. This participation, which included presenting at a Demo Day to international venture capitalists, signals strong validation of Intimo Medical's innovation in the.
Log in to access full profile ›Company Intelligence Q&A
- When was Intimo Medical founded?
- Intimo Medical was founded in November 2022.
- Who are the founders of Intimo Medical?
- Intimo Medical was founded by Lior Erez and Matan Shabat.
- What is Intimo Medical's primary product?
- Intimo Medical develops a versatile Intrauterine 3-Dimensional Device (IU3D) designed for hormone-free contraception and future clinical indications.
- What significant grant did Intimo Medical receive?
- In May 2025, Intimo Medical received a grant from the Israel Innovation Authority.
- What was Intimo Medical's involvement with Open Accelerator?
- In December 2024, Intimo Medical was selected for the Open Accelerator program, promoted by Zcube – Zambon Research Venture, and presented its innovations at a Demo Day.